Average Insider

Where insiders trade, we follow

Xilio Therapeutics, Inc. ($XLO)
Frankenfield Christopher James โ€“ Chief Financial Officer
Dec 31, 2025
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$6.47
Current$7.298.2% above low, 91.8% below high
52W High$16.52
Shares
668,789
Price
$0.00
Total Value
$0.00

Nearby Earnings

No earnings within 2 weeks of this transaction.

Transaction Details

InsiderFrankenfield Christopher James
TitleChief Financial Officer
Transaction DateDec 31, 2025
Expiration DateOct 7, 2035
Transaction CodeA Grant/Award
Acquired/DisposedAcquired
Security
Stock Option (right to buy)
(Common Stock)
DerivativeYes
Direct/IndirectDirect
Filing DateJan 5, 2026
Shares Purchased668,789
Price per Share$0.00
Total Value$0.00
Shares Owned After668,789
DerivativeDerivative
(Common Stock)
Accession Number0001193125-26-002517
DocumentView SEC Filing
Version: v26.3.29